Home › Forums › Mad Money Stock Archive (ジム・クレイマーの銘柄紹介) › Mad Money with Jim Cramer – Mar 19, 2026 (Thur): Key Points & Links|要点・関連リンク
- This topic is empty.
-
AuthorPosts
-
-
March 26, 2026 at 1:04 am #3026
Jun Kurema (暮眞★潤)
KeymasterThis page lists the main topics and stocks discussed on Mad Money with Jim Cramer aired on March 19, 2026, with links to CNBC articles, videos, and English transcripts.
2026年3月19日放送の 「Mad Money with Jim Cramer」 で取り上げられた主な話題・銘柄を、CNBCの記事・動画・英文トランスクリプトへのリンクとともに一覧化しています。
(1) Jim Cramer says ‘sometimes you have to hold your nose’ and buy stocks (https://www.cnbc.com/2026/03/19/jim-cramer-sometimes-you-have-to-hold-your-nose-and-buy-stocks.html)
- CNBC’s Jim Cramer said that investors should hold their noses and buy.
- Cramer points to the S&P Short Range Oscillator’s extremely oversold levels as a marker for a potential future rally.
“Bottom Line: History says when we get his oversold, there will be a meaningful rally.”
(2) [No Video Clip for non-Club members] Executive Interview: Winnie Park is a miracle worker at Five Below, says Jim Cramer (https://www.cnbc.com/video/2026/03/19/winnie-park-is-a-miracle-worker-at-five-below-says-jim-cramer.html)
‘Mad Money’ host Jim Cramer reflects on the rebound of discount retailer Five Below.
Ticker: FIVE
(3) [No Video Clip for non-Club members] Macro noise masked a real win in Johnson & Johnson, says Jim Cramer (https://www.cnbc.com/video/2026/03/19/macro-noise-masked-a-real-win-in-johnson-johnson-says-jim-cramer.html)
‘Mad Money’ host Jim Cramer looks at a buying opportunity in a winning pharmaceutical stock amid market turmoil.
Ticker: JNJ [great buying opportunity here]
(4) [No Video Clip for non-Club members] Executive Interview: Signet Jewelers CEO J.K. Symancyk goes one-on-one with Jim Cramer (https://www.cnbc.com/video/2026/03/19/signet-jewelers-ceo-jk-symancyk-goes-one-on-one-with-jim-cramer.html)
Signet Jewelers CEO J.K. Symancyk joins ‘Mad Money’ host Jim Cramer to talk the state of the jewelry market, its quarterly results, strengthening its balance sheet, and more.
Ticker: SIG
(5) Lightning Round: I can’t recommend Stellantis, says Jim Cramer (https://www.cnbc.com/video/2026/03/19/lightning-round-i-cant-recommend-stellantis-says-jim-cramer.html)
‘Mad Money’ host Jim Cramer weighs in on stocks including: Immunitybio, Skyworks Solutions, Stellantis, Element Solutions, GE Vernova, and Carnival.
Ticker: Immunitybio (IBRK) [IBRK had a big crossing of a huge amount of stock right at the end; I don’t know where that stock went to; I’d like to see the stock come in and see if that block holds before I buy], Skyworks Solutions (SWKS) [problem with Skyworkds is that it’s totally cell phone, it just doesn’t have enough, it’s got to merge with someone] cannot recommend; don’t buy], Stellantis (STLA) [I cannot recommend; don’t buy], Element Solutions (ESI) [that sounds like a good story; I don’t know the stock enough but will learn], GE Vernova (GEV) [upstock, best book of business; buy buy buy], Carnival (CCL) [I like the upgrade; buy buy buy].
(6) [No Video Clip for non-Club members] Nothing is harder than buying a stock when it’s in a tailspin, says Jim Cramer (https://www.cnbc.com/video/2026/03/19/nothing-is-harder-than-buying-a-stock-when-its-in-a-tailspin-says-jim-cramer.html)
‘Mad Money’ host Jim Cramer talks the bull case for Dell Technologies.
Ticker: DELL [buy in a pyramid style]
Other Stocks Discussed (calls with audience)/ この日の放送で取り上げられたその他の銘柄(視聴者からの電話): Reddit (RDDT) [incredibly great stock; sticking by; buy right here; buy buy buy], Intuitive Surgical (ISRG) [stock is good but multiple is too high; too expensive], Booking Holdings (BKNG) [25 to 1 split; cannot buy 4 weeks wright after the split; but I like the stock]
Ref: Links related to this episode /参考: この日の放送に関するその他のサイトへのリンク:
- Podcast at Spotify (Sound /音声)
- InternetArchive(Video & Texts per minute /1分毎のビデオ&テキスト)
****************************
Previous Episode/ 前回のエピソード Next Episode / 次回のエピソード
-
-
AuthorPosts
- The forum ‘Mad Money Stock Archive (ジム・クレイマーの銘柄紹介)’ is closed to new topics and replies.